Effectiveness of leukotriene receptor antagonists for dysmenorrhea of endometriosis.
letter
OA: closed
CC0
⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated the effectiveness of leukotriene receptor antagonists in treating dysmenorrhea associated with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (6)
- Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats? 2014
- Towards an understanding of the molecular mechanism of endometriosis: unbalancing epithelial-stromal genetic conflict 2013
- Studying the Effect of Montelukast in the Treatment of Dysmenorrhea: A single-Blind, Placebo-controlled Trial 2012
- The role of iron in the pathogenesis of endometriosis 2009
- Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: A prospective, double-blind, randomized, placebo-controlled study 2009
- Role of immunoreactions and mast cells in pathogenesis of human endometriosis -morphologic study and gene expression analysis- 2003
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK